Ylva Gravenfors

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Candida Albicans

Molecular Docking

Top Venues

Molecules (Basel, Switzerland)

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Christoffer Bengtsson, Ylva Gravenfors
Rapid Construction of a Chloromethyl-Substituted Duocarmycin-like Prodrug. Molecules (Basel, Switzerland) 28 (12) (2023)
Christoffer Bengtsson, Ylva Gravenfors
Rapid Construction of a Chloromethyl-Substituted Duocarmycin-like Prodrug. Molecules (Basel, Switzerland) 28 (12) (2023)
Christoffer Bengtsson, Ylva Gravenfors
Rapid Construction of a Chloromethyl-Substituted Duocarmycin-like Prodrug. Molecules (Basel, Switzerland) 28 (12) (2023)
Andreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, Duy Duc Vo, Dario Akaberi, Vladimir O Talibov, Natalia Nekhotiaeva, Laura Vangeel, Steven De Jonghe, Dirk Jochmans, Janina Krambrich, Ali Tas, Bo Lundgren, Ylva Gravenfors, Alexander J Craig, Yoseph Atilaw, Anja Sandström, Lindon W K Moodie, Åke Lundkvist, Martijn J van Hemert, Johan Neyts, Johan Lennerstrand, Jan Kihlberg, Kristian Sandberg, U Helena Danielson, Jens Carlsson
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses. Journal of the American Chemical Society 144 (7) (2022)